Clinical trial
Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of…
NCT00371878 · Royal Liverpool University Hospital, Other · Completed
Key facts
| NCT number | NCT00371878 |
|---|---|
| Title | Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection |
| Official title | Open Label Study of Lung and Serum Immunoglobulin Responses to 7-Valent Pneumococcal Conjugate Vaccine in HIV Infected and Non-HIV Infected Malawian Adults |
| Lead sponsor | Royal Liverpool University Hospital, Other |
| Collaborators | Kamuzu University of Health Sciences Liverpool School of Tropical Medicine Wellcome Trust |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pneumonia, Meningitis, Invasive Pneumococcal Disease, HIV |
| Intervention type | Biological |
| Interventions | 7-valent pneumococcal conjugate vaccine (Prevnar) |
| Enrollment | 40 |
| Start date | Feb 1, 2003 |
| Completion | Oct 1, 2003 |
| First posted | Sep 4, 2006 |
| Last update posted | Aug 8, 2008 |
| Countries | Malawi |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: